Cargando…

Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis

Staphylococcus epidermidis is a significant opportunistic pathogen of humans. The ST2 lineage is frequently multidrug-resistant and accounts for most of the clinical disease worldwide. However, there are no publically available, closed ST2 genomes and pathogenesis studies have not focused on these s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jean Y. H., Monk, Ian R., Pidot, Sacha J., Singh, Siddarth, Chua, Kyra Y. L., Seemann, Torsten, Stinear, Timothy P., Howden, Benjamin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537629/
https://www.ncbi.nlm.nih.gov/pubmed/28785416
http://dx.doi.org/10.1099/mgen.0.000077
_version_ 1783254216469381120
author Lee, Jean Y. H.
Monk, Ian R.
Pidot, Sacha J.
Singh, Siddarth
Chua, Kyra Y. L.
Seemann, Torsten
Stinear, Timothy P.
Howden, Benjamin P.
author_facet Lee, Jean Y. H.
Monk, Ian R.
Pidot, Sacha J.
Singh, Siddarth
Chua, Kyra Y. L.
Seemann, Torsten
Stinear, Timothy P.
Howden, Benjamin P.
author_sort Lee, Jean Y. H.
collection PubMed
description Staphylococcus epidermidis is a significant opportunistic pathogen of humans. The ST2 lineage is frequently multidrug-resistant and accounts for most of the clinical disease worldwide. However, there are no publically available, closed ST2 genomes and pathogenesis studies have not focused on these strains. We report the complete genome and methylome of BPH0662, a multidrug-resistant, hospital-adapted, ST2 S. epidermidis, and describe the correlation between resistome and phenotype, as well as demonstrate its relationship to publically available, international ST2 isolates. Furthermore, we delineate the methylome determined by the two type I restriction modification systems present in BPH0662 through heterologous expression in Escherichia coli, allowing the assignment of each system to its corresponding target recognition motif. As the first, to our knowledge, complete ST2 S. epidermidis genome, BPH0662 provides a valuable reference for future genomic studies of this clinically relevant lineage. Defining the methylome and the construction of these E. coli hosts provides the foundation for the development of molecular tools to bypass restriction modification systems in this lineage that has hitherto proven intractable.
format Online
Article
Text
id pubmed-5537629
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Microbiology Society
record_format MEDLINE/PubMed
spelling pubmed-55376292017-08-07 Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis Lee, Jean Y. H. Monk, Ian R. Pidot, Sacha J. Singh, Siddarth Chua, Kyra Y. L. Seemann, Torsten Stinear, Timothy P. Howden, Benjamin P. Microb Genom Microbial evolution and epidemiology: Mechanisms of evolution Staphylococcus epidermidis is a significant opportunistic pathogen of humans. The ST2 lineage is frequently multidrug-resistant and accounts for most of the clinical disease worldwide. However, there are no publically available, closed ST2 genomes and pathogenesis studies have not focused on these strains. We report the complete genome and methylome of BPH0662, a multidrug-resistant, hospital-adapted, ST2 S. epidermidis, and describe the correlation between resistome and phenotype, as well as demonstrate its relationship to publically available, international ST2 isolates. Furthermore, we delineate the methylome determined by the two type I restriction modification systems present in BPH0662 through heterologous expression in Escherichia coli, allowing the assignment of each system to its corresponding target recognition motif. As the first, to our knowledge, complete ST2 S. epidermidis genome, BPH0662 provides a valuable reference for future genomic studies of this clinically relevant lineage. Defining the methylome and the construction of these E. coli hosts provides the foundation for the development of molecular tools to bypass restriction modification systems in this lineage that has hitherto proven intractable. Microbiology Society 2016-09-20 /pmc/articles/PMC5537629/ /pubmed/28785416 http://dx.doi.org/10.1099/mgen.0.000077 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution 4.04.0 International License (http://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
spellingShingle Microbial evolution and epidemiology: Mechanisms of evolution
Lee, Jean Y. H.
Monk, Ian R.
Pidot, Sacha J.
Singh, Siddarth
Chua, Kyra Y. L.
Seemann, Torsten
Stinear, Timothy P.
Howden, Benjamin P.
Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis
title Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis
title_full Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis
title_fullStr Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis
title_full_unstemmed Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis
title_short Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis
title_sort functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 staphylococcus epidermidis
topic Microbial evolution and epidemiology: Mechanisms of evolution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537629/
https://www.ncbi.nlm.nih.gov/pubmed/28785416
http://dx.doi.org/10.1099/mgen.0.000077
work_keys_str_mv AT leejeanyh functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis
AT monkianr functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis
AT pidotsachaj functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis
AT singhsiddarth functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis
AT chuakyrayl functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis
AT seemanntorsten functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis
AT stineartimothyp functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis
AT howdenbenjaminp functionalanalysisofthefirstcompletegenomesequenceofamultidrugresistantsequencetype2staphylococcusepidermidis